KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Short term Debt (2016 - 2025)

Tenet Healthcare's Short term Debt history spans 17 years, with the latest figure at $79.0 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 14.13% year-over-year to $79.0 million; the TTM value through Dec 2025 reached $79.0 million, down 14.13%, while the annual FY2025 figure was $79.0 million, 14.13% down from the prior year.
  • Short term Debt for Q4 2025 was $79.0 million at Tenet Healthcare, down from $85.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $148.0 million in Q1 2023 and bottomed at $79.0 million in Q4 2025.
  • The 5-year median for Short term Debt is $125.0 million (2021), against an average of $117.0 million.
  • The largest annual shift saw Short term Debt rose 12.8% in 2023 before it tumbled 32.62% in 2024.
  • A 5-year view of Short term Debt shows it stood at $135.0 million in 2021, then increased by 7.41% to $145.0 million in 2022, then fell by 17.24% to $120.0 million in 2023, then decreased by 23.33% to $92.0 million in 2024, then dropped by 14.13% to $79.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Short term Debt are $79.0 million (Q4 2025), $85.0 million (Q3 2025), and $84.0 million (Q2 2025).